Literature DB >> 8423361

Locomotion through three-dimensional type I rat tail collagen. A modified mini-assay.

H Gutman1, D Risin, B P Katz, N R Pellis.   

Abstract

There is an increased application of three-dimensional type I rat tail collagen as an in vitro model for the peritumoral matrix in analysis of lymphocyte migration. The increased demand prompted us to modify the previous methods. We here describe our 'mini'-setup of the collagen model assay, which uses only 1/20 the amount of collagen medium and the number of cells used in the conventional assay. The modified assay was tested for optimal collagen concentration in gel for upward and downward migration, for locomotion from a collagen-gel bead into a collagen overlayer for demonstration of the effect of inhibitors and for differentiation between locomotory properties of lymphocyte subpopulations. The results verify that the mini-assay is an applicable in vitro model, easily read and amenable to limited blood samples such as those obtained from cancer patients, and reflects well known in vivo events.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423361     DOI: 10.1016/0022-1759(93)90084-k

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Suppression of antigen-specific lymphocyte activation in modeled microgravity.

Authors:  D Cooper; M W Pride; E L Brown; D Risin; N R Pellis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-02       Impact factor: 2.416

2.  Changes in gravity inhibit lymphocyte locomotion through type I collagen.

Authors:  N R Pellis; T J Goodwin; D Risin; B W McIntyre; R P Pizzini; D Cooper; T L Baker; G F Spaulding
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

3.  Loss of signal transduction and inhibition of lymphocyte locomotion in a ground-based model of microgravity.

Authors:  Alamelu Sundaresan; Diana Risin; Neal R Pellis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-02       Impact factor: 2.416

4.  Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated muramyl-tripeptide-phosphatidylethanolamine.

Authors:  D Risin; E S Kleinerman; Y Umezu; R P Pizzini; C M Balch; N R Pellis
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.